Molecular Medicine Reports,
Journal Year:
2024,
Volume and Issue:
31(2)
Published: Nov. 29, 2024
Long
noncoding
RNA
(lncRNA)
PTTG3P
has
been
demonstrated
to
participate
in
the
development
of
hepatocellular
carcinoma
(HCC)
by
targeting
mRNA
PTTG1.
The
present
study
aimed
investigate
diagnostic
efficacy
serum
lncRNA
PTTG3P,
PTTG1
and
their
combination
for
diagnosis
prognosis
HCC.
A
total
373
participants
were
enrolled
study,
including
73
patients
with
HCC,
100
chronic
hepatitis
B
(CHB),
liver
cirrhosis
(LC)
healthy
controls
(HCs).
expression
levels
RNAs
quantified
reverse
transcription‑quantitative
PCR.
association
between
clinical
characteristics
was
further
analyzed.
Receiver
operating
characteristic
(ROC)
curve
area
under
(AUC)
analyses
performed
estimate
ability
combinations
other
biomarkers
results
revealed
that
markedly
increased
HCC
CHB
compared
HCs.
Additionally,
postoperative
significantly
lower
than
preoperative
concentrations
36
paired
Spearman's
correlation
coefficient
analysis
showed
correlated
aspartate
transaminase
(AST).
ROC
both
had
a
significant
predictive
value
AUC
values
alone
0.636
0.634,
respectively.
Furthermore,
combining
PTTG1,
α‑fetoprotein
(AFP),
alanine
aminotransferase
(ALT),
AST,
γ‑glutamyl
transpeptidase
(GGT)
alkaline
phosphatase
(ALP)
value.
best
performance
AFP,
ALT,
GGT
ALP
an
0.959,
sensitivity
90.4%
specificity
98.0%.
In
conclusion,
AFP
appeared
be
noninvasive
biomarker
comparatively
high
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: March 17, 2025
Osteosarcoma,
the
most
common
primary
bone
cancer
in
children
and
adolescents,
presents
significant
challenges,
particularly
metastasis
recurrence,
resulting
poor
survival
rates.
This
study
explores
role
of
PANoptosis—a
complex
cell
death
mechanism
involving
pyroptosis,
apoptosis,
necroptosis—in
osteosarcoma
by
identifying
relevant
long
non-coding
RNAs
(lncRNAs)
their
prognostic
significance.
Bioinformatics
analyses
used
RNA
expression
data
from
GEO
TARGET
databases
to
identify
differentially
expressed
genes
(DEGs)
PANoptosis-related
(PRGs).
Co-expression
analysis
revealed
lncRNAs
linked
PRGs,
forming
a
risk
model.
Five
PRGs
two
were
significantly
associated
with
prognosis,
model
showing
high
predictive
accuracy
(AUC
0.876,
0.787,
0.794
for
1,
3,
5
years).
Notably,
lncRNA
AC133552.2
was
downregulated
tissues,
correlating
reduced
immune
infiltration.
Silencing
promoted
proliferation
migration,
while
overexpression
inhibited
tumor
growth
metastasis,
confirmed
xenograft
models.
emerges
as
potential
biomarker
therapeutic
target,
future
research
needed
explore
its
molecular
mechanisms
clinical
application.
Clinical and Experimental Medicine,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: May 14, 2025
Liver
disease
(LD)
is
complex
pathological
condition
that
has
emerged
as
a
major
threat
to
human
health
and
the
quality
of
life.
Nonetheless,
molecular
mechanisms
underlying
pathogenesis
LD
have
not
yet
been
fully
elucidated.
Recently,
large
amount
evidence
shown
long
noncoding
RNAs
(lncRNAs)
play
important
roles
in
diverse
biological
processes
liver.
The
dysregulation
lncRNAs
liver,
for
example,
can
affect
tumor
proliferation,
migration,
invasion,
contribute
hepatic
metabolism
disorder
lipid
glucose,
shape
tumoral
microenvironment.
Thus,
comprehensive
understanding
functional
may
provide
new
perspectives
development
novel
diagnostic
therapeutic
tools.
In
present
review,
we
summarize
current
findings
on
relationship
between
LD,
including
modes
action
lncRNAs,
significance
especially
hepatocellular
carcinoma
(HCC)
well
some
non-neoplastic
disorders,
potential
use
biomarkers
targets
LD.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(3), P. 1587 - 1587
Published: Jan. 27, 2024
Papillary
thyroid
carcinoma
(PTC)
is
the
most
common
histological
category
of
cancer.
In
recent
years,
there
has
been
an
increasing
number
studies
on
lncRNAs
in
PTC.
Long
intergenic
non-protein
coding
RNA
887
(LINC00887)
a
critical
oncogene
developing
other
cancers.
LINC00887
upregulated
PTC
samples
but
its
role
currently
unclear.
This
study
aimed
to
investigate
impact
disruption
expression
progression.
We
performed
CRISPR/Cas9
strategy
for
truncation
BCPAP
and
TPC1
cell
lines.
Functional
assays
showed
that
knockdown
both
cells
reduced
proliferation,
colony
formation
migration,
delayed
cycle,
increased
apoptosis.
These
results
strengthened
cancer
first
time
this
lncRNA
could
be
potential
PTC,
acting
as
tumor
promoter.
Modulation
immune
system
may
one
etiopathogenic
mechanisms
shown
by
observed
influence
PD-L1
expression.
addition,
biological
pathways
identified
date,
such
EMT,
Wnt/β-catenin
signaling
pathway
or
FRMD6-Hippo
also
relevant
regulatory
operating
Discover Oncology,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Oct. 10, 2024
Sorafenib,
a
first-line
therapeutic
option
for
advanced
hepatocellular
carcinoma
(HCC),
faces
formidable
challenge
in
the
form
of
emerging
resistance.
Recently,
oncogene
DDX11
antisense
RNA
1
(DDX11-AS1)
has
been
implicated
various
cancers,
including
HCC.
However,
its
role
sorafenib
resistance
remains
unknown.
Our
findings
reveal
that
DDX11-AS1
is
upregulated
sorafenib-resistant
HCC
cells,
contributing
to
their
by
suppressing
ferroptosis.
Further
investigation
elucidated
mechanism
which
activates
antioxidant
Nrf2-Keap1
pathway.
By
interacting
with
Nrf2
and
hindering
association
Keap1,
enhances
stability
nuclear
translocation
Nrf2.
In
summary,
our
study
unveils
potent
as
an
enhancer
resistance,
inhibiting
sorafenib-induced
ferroptosis
through
activation
pathway
These
offer
promising
strategy
overcome
effectively
treat
Frontiers in Bioscience-Landmark,
Journal Year:
2023,
Volume and Issue:
28(12)
Published: Dec. 19, 2023
Background:
The
functional
ramifications
of
internal
N7-methylguanosine
(m7G)
modification
on
RNAs
have
recently
come
to
light,
yet
its
regulatory
influence
long
noncoding
(lncRNAs)
during
the
inflammatory-carcinogenesis
transformation
process
in
hepatitis
B
virus
(HBV)-mediated
hepatocellular
carcinoma
(HCC)
remains
largely
unexplored.
Methods:
Clinical
surgical
samples
encompassing
HBV-related
HCC,
comprising
both
HCC
tissue
(tumor
group,
HBV+)
and
corresponding
adjacent
liver
(paracancerous
HBV+),
were
collected
for
analysis.
Additional
normal
tissues
(normal
HBV-)
acquired
from
patients
with
hepatic
hemangioma,
serving
as
controls.
Employing
MeRIP-seq,
differential
m7G
levels
lncRNAs
across
these
groups
compared
identify
a
subset
exhibiting
continuous
dynamic
changes
modification.
Subsequently,
vitro
validation
was
conducted.
Results:
A
total
856
exhibited
alterations
when
paracancerous
tissue.
Similarly,
1775
displayed
comparing
For
intergroup
comparison,
orthogonal
analysis
revealed
that
6
consistently
demonstrated
hyper-m7G
In
confirmed
among
lncRNAs,
TEKT4P2
DNM1P41
modification-dependent
expression.
Conclusions:
This
study
provides
comprehensive
lncRNA
HBV-mediated
HCC.
findings
highlight
potential
multiple
undergo
changes,
identified
promising
molecular
targets
within
this
intricate
landscape.
American Journal of Cancer Research,
Journal Year:
2024,
Volume and Issue:
14(3), P. 996 - 1014
Published: Jan. 1, 2024
RNASEH1-AS1,
a
long
non-coding
RNA
(lncRNA)
divergently
transcribed
from
the
antisense
strand
of
its
neighboring
protein-coding
gene
ribonuclease
H1
(RNASEH1),
has
recently
been
demonstrated
to
be
involved
in
tumor
progression.
However,
association
between
RNASEH1-AS1
and
hepatocellular
carcinoma
(HCC)
remains
unclear.
In
present
study,
first,
expression
HCC
correlation
with
clinicopathological
features,
prognosis,
diagnosis,
immune
cell
infiltration
patients
was
inspected
using
relevant
R
packages
based
on
The
Cancer
Genome
Atlas
(TCGA)
data.
found
up-regulated
most
cancer
types,
including
HCC,
overexpression
significantly
associated
histologic
grade
AFP
level
as
well
poor
an
independent
risk
factor
affecting
overall
survival
good
diagnostic
prognostic
values
for
HCC.
inversely
plasmacytoid
dendritic
cells
(pDC),
B
neutrophils.
Second,
total
1109
positively
co-expressed
genes
(PCEGs)
were
screened
out
by
analysis
batches
(|Spearman's
r|
>0.4
adjusted
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: July 8, 2024
ABSTRACT
The
CDKN2A
gene,
responsible
for
encoding
the
tumor
suppressors
p16(INK4A)
and
p14(ARF),
is
frequently
inactivated
in
non-small
cell
lung
cancer
(NSCLC).
Herein,
an
uncharacterized
long
non-coding
RNA
(lncRNA)
(ENSG00000267053)
on
chromosome
19p13.12
was
found
to
be
overexpressed
NSCLC
cells
with
active,
wild-type
gene.
This
lncRNA,
named
Cy
clin-Dependent
K
inase
I
nhibitor
2A-regulated
l
nc
R
NA
(CyKILR),
also
correlated
active
WT
STK11
which
encodes
suppressor,
Liver
kinase
B1.
CyKILR
displayed
two
splice
variants,
CyKILRa
(exon
3
included)
CyKILRb
excluded),
are
cooperatively
regulated
by
as
knockdown
of
both
suppressor
genes
required
induce
a
significant
loss
exon
inclusion
mature
RNA.
localized
nucleus,
its
downregulation
using
antisense
oligonucleotides
enhanced
cellular
proliferation,
migration,
clonogenic
survival,
incidence.
In
contrast,
cytoplasm,
siRNA
reduced
Transcriptomics
analyses
revealed
enhancement
apoptotic
pathways
concomitant
suppression
key
cycle
demonstrating
tumor-suppressive
role.
inhibited
microRNAs
indicating
oncogenic
nature.
These
findings
elucidate
intricate
roles
lncRNAs
signaling
tumorigenesis.